Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    3352672 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Talampanel to Treat Parkinson's Disease
Condition: Parkinson Disease
Interventions: Drug: IV Levodopa;   Drug: Talampanel
2 Completed Levetiracetam Treatment of L-Dopa Induced Dyskinesias
Conditions: Dyskinesias;   Parkinson Disease
Intervention: Drug: Intravenous Levodopa

Indicates status has not been verified in more than two years